Ibrutinib is a non-receptor Bruton's tyrosine kinase inhibitor approved for the treatment of relapsed chronic lymphocytic leukemia(CLL), mantle cell lymphoma (MCL) and WaldenstrÖm's Macroglobulinemia (WM).
Melting point:153-158°C
Boiling point:715.0±60.0 °C(Predicted)
Density:1.34
Storage temp:-20°C
Solubility:Soluble in DMSO ( up to at least 25 mg/ml)
Pka:4.09±0.30(Predicted)
Form:solid
Color :White or off-white
Stability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
